Ovarian Neoplasms Concept

subject area of

• "Mesonephroma" of the ovary. A report of five cases.  Journal Articles
• ets‐1is transcriptionally up‐regulated by H₂O₂via an antioxidant response element  Journal Articles
• A CASE OF MASCULINIZING OVARIAN TUMOR: USE OF CORTICOSTEROID INHIBITION TEST IN DIAGNOSIS  Journal Articles
• A Comparison of Two Prophylactic Regimens for Hypersensitivity Reactions to Paclitaxel  Journal Articles
• A New Series of Succinimido-ferrociphenols and Related Heterocyclic Species Induce Strong Antiproliferative Effects, Especially against Ovarian Cancer Cells Resistant to Cisplatin  Journal Articles
• A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers  Journal Articles
• A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer  Journal Articles
• A Randomized Trial of Paracentesis plus Intraperitoneal Tumor Necrosis Factor-α versus Paracentesis Alone in Patients with Symptomatic Ascites from Recurrent Ovarian Carcinoma  Journal Articles
• A case control study of carcinoma of the ovary.  Journal Articles
• A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genes  Journal Articles
• A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia  Journal Articles
• A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)  Journal Articles
• A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia  Journal Articles
• A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study  Journal Articles
• A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study  Journal Articles
• A predictive index of cure versus no cure in advanced ovarian carcinoma patients—Replacement of second-look laparotomy as a diagnostic test  Journal Articles
• A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer  Journal Articles
• A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinoma  Journal Articles
• A systematic review of patient values, preferences and expectations for the treatment of recurrent ovarian cancer  Journal Articles
• A unique BRCA1 mutation identified in Mongolia  Journal Articles
• AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma  Journal Articles
• ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer  Journal Articles
• ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer  Journal Articles
• ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass, No Acute Symptoms  Journal Articles
• Acoustic streaming cannot discriminate reliably between endometriomas and other types of adnexal lesion: a multicenter study of 633 adnexal masses  Journal Articles
• Addition of Pentoxifylline plus Nifedipine to Chemotherapy in Patients with Cisplatin-Resistant Cancers of the Lung and Other Sites  Journal Articles
• Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer  Journal Articles
• Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma  Journal Articles
• Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel  Journal Articles
• Akt isoform specific effects in ovarian cancer progression  Journal Articles
• An Endodermal Sinus Tumor Diagnosed in Pregnancy: Case Report and Review of the Literature  Journal Articles
• An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma  Journal Articles
• An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool  Journal Articles
• Autocrine VEGF‐A/KDR loop protects epithelial ovarian carcinoma cells from anoikis  Journal Articles
• Autoimmune haemolytic anaemia associated with ovarian dermoid cyst  Journal Articles
• Bilateral Lymphangiomas of the Ovary  Journal Articles
• Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations  Journal Articles
• Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal  Journal Articles
• Body mass index in relation to ovarian cancer: A multi‐centre nested case‐control study  Journal Articles
• Breast and ovarian cancer risk perception after prophylactic salpingo‐oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene  Journal Articles
• Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation  Journal Articles
• Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers  Journal Articles
• CXCR6 by increasing retention of memory CD8⁺ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer  Journal Articles
• Cancer health effects of pesticides - Systematic review  Journal Articles
• Cancer health effects of pesticides: systematic review.  Journal Articles
• Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial  Journal Articles
• Carboplatin hypersensitivity presenting as coronary vasospasm - a case report  Journal Articles
• Care Delivery Patterns, Processes, and Outcomes for Primary Ovarian Cancer Surgery: A Population-Based Review Using a National Administrative Database  Journal Articles
• Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial  Journal Articles
• Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial  Journal Articles
• Cell Junctions in Lymphomas: Study of a Primary Ovarian T-Cell Lymphoma and Review of Fifty-Six Other Cases of Lymphoma  Journal Articles
• Challenges in Experimental Modeling of Ovarian Cancerogenesis  Journal Articles
• Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C  Journal Articles
• Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer  Journal Articles
• Chemotherapy for recurrent epithelial ovarian cancer previously treated with platinum--a systematic review of the evidence from randomized trials.  Journal Articles
• Chemotherapy of advanced ovarian carcinoma: Initial experience using a platinum-based combination  Journal Articles
• Choices of Methodology in Pharmacoeconomic Studies  Journal Articles
• Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer  Journal Articles
• Circulating levels of insulin‐like growth factor‐I and risk of ovarian cancer  Journal Articles
• Circulating levels of sex steroid hormones and risk of ovarian cancer  Journal Articles
• Circulating prolactin levels and risk of epithelial ovarian cancer  Journal Articles
• Circulating soluble Fas levels and risk of ovarian cancer  Journal Articles
• Clinical Management Recommendations for Surveillance and Risk-Reduction Strategies for Hereditary Breast and Ovarian Cancer Among Individuals Carrying a Deleterious BRCA1 or BRCA2 Mutation  Journal Articles
• Combined therapy with thrombospondin‐1 type I repeats (3TSR) and chemotherapy induces regression and significandy improves survival in a preclinical model of advanced stage epithelial ovarian cancer  Journal Articles
• Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer  Journal Articles
• Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer  Journal Articles
• Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer  Journal Articles
• Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review  Journal Articles
• Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation  Journal Articles
• Cytokine elevations in acute coronary syndrome and ovarian cancer: A mechanism for the up-regulation of the acute phase proteins in these different disease etiologies  Journal Articles
• DEVELOPMENT OF ANTI-IDIOTYPIC ANTIBODIES AGAINST TUMOUR ANTIGENS AND AUTOANTIGENS IN OVARIAN CANCER PATIENTS TREATED INTRAPERITONEALLY WITH MOUSE MONOCLONAL ANTIBODIES  Journal Articles
• Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study  Journal Articles
• Desmoplastic Small Round Cell Tumor (DSRCT) With Ovarian Involvement in 2 Young Women  Journal Articles
• Desmoplastic small round cell tumor presenting in the ovaries: Report of a case and review of the literature  Journal Articles
• Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines.  Journal Articles
• Diagnosing endometriosis: CA125 rules in, but not out  Journal Articles
• Do Deeper Sections Increase the Frequency of Detection of Serous Tubal Intraepithelial Carcinoma (STIC) in the “Sectioning and Extensively Examining the FIMbriated End” (SEE-FIM) Protocol?  Journal Articles
• Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221  Journal Articles
• Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report.  Journal Articles
• Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspective.  Journal Articles
• Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary  Journal Articles
• Editorial comment on Leung et al.: CUB and zona pellucida-like domain-containing protein 1 (CUZD1): A novel serological biomarker for ovarian cancer  Journal Articles
• Effect of radiation and other cytotoxic agents on the growth of cells cultured from normal and tumor tissues from the female genital tract  Journal Articles
• Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer  Journal Articles
• Endodermal Sinus Tumor in Pregnancy  Journal Articles
• Endometrioid Cystadenofibroma of the Ovary with Pelvic Lymph Node Involvement  Journal Articles
• Endometriosis-Associated Ovarian Carcinomas  Journal Articles
• Endometriosis: Diagnosis and Management  Journal Articles
• Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer  Journal Articles
• Energetic characteristics of cisplatin resistant ovarian carcinoma cells.  Journal Articles
• Epileptic seizures associated with cisplatin administration.  Journal Articles
• Epithelial–stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer  Journal Articles
• Establishment and characterization of four human epithelial ovarian carcinoma cell lines  Journal Articles
• Ets-1 Regulates Energy Metabolism in Cancer Cells  Journal Articles
• Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer  Journal Articles
• Evaluation of antitumor property of extracts and steroidal alkaloids from the cultivated Bulbus Fritillariae ussuriensis and preliminary investigation of its mechanism of action.  Journal Articles
• Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.  Conferences
• Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap  Journal Articles
• Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells  Journal Articles
• Exon 5 of the p53 gene is a target for deletions in ovarian cancer  Journal Articles
• Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model  Journal Articles
• Expression of the prostate-specific antigen gene by a primary ovarian carcinoma.  Journal Articles
• FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper  Journal Articles
• Factors determining the ability of cytokine-activated killer cells to lyse human ovarian carcinoma targets  Journal Articles
• Familial ovarian cancer.  Journal Articles
• Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors  Journal Articles
• Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer  Journal Articles
• First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG  Journal Articles
• Follicular Variant Papillary Thyroid Carcinoma Arising in Struma Ovarii  Journal Articles
• Foreign Body Reaction Mimicking Breast Carcinoma in Patient with Stage IV Ovarian Cancer  Journal Articles
• Frequency of Serous Tubal Intraepithelial Carcinoma in Various Gynecologic Malignancies  Journal Articles
• Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG  Journal Articles
• Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-β as a suppressive factor  Journal Articles
• Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario  Journal Articles
• Getting to the heart of the problem: a case report on the use of emergency department ultrasonography in a patient with shortness of breath.  Journal Articles
• Guideline No. 403: Initial Investigation and Management of Adnexal Masses  Journal Articles
• HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis  Journal Articles
• Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference  Journal Articles
• Hip hemiarthroplasty periprosthetic loosening caused by papillary ovarian carcinoma metastasis in a 78-year-old woman: a rare presentation and a literature review.  Journal Articles
• Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers  Journal Articles
• How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter  Journal Articles
• Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property  Journal Articles
• Human ovarian carcinoma: evidence for patient-related differences in susceptibility to cytotoxic effectors that attack different cellular subpopulations within a tumour  Journal Articles
• Hyperglycemia promotes insulin-independent ovarian tumor growth  Journal Articles
• IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival  Journal Articles
• IOTA Simple Rules: Review of 10 Points for Evaluation of Adnexal Masses  Journal Articles
• Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer  Journal Articles
• Ignored Because It Is Benign – It Is Time to Treat Endometriosis as if It Were Cancer  Journal Articles
• Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.  Journal Articles
• Immunohistochemical localization of tyrosine receptor kinases A and B in endometriosis‐associated ovarian cancer  Journal Articles
• Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee  Journal Articles
• Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family Registry for Breast Cancer Studies  Journal Articles
• Influence of the proto-oncogene c-fos on cisplatin sensitivity  Journal Articles
• Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer  Journal Articles
• International Gynecologic Cancer Society (IGCS 2012)  Journal Articles
• Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas  Conferences
• Intraoperative predictors of appendiceal abnormalities in patients with mucinous ovarian neoplasms  Journal Articles
• Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer  Journal Articles
• Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study  Journal Articles
• Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?  Journal Articles
• Is incidental prophylactic oophorectomy an acceptable means to reduce the incidence of ovarian cancer?  Journal Articles
• It's a choice to move forward: women's perceptions about treatment decision making in recurrent ovarian cancer  Journal Articles
• Jnk1 activity lowers the cellular production of H2O2 and modulates the growth arrest response to scavenging of H2O2 by catalase  Journal Articles
• Kaiso regulates Znf131-mediated transcriptional activation  Journal Articles
• Linkage analysis of 26 Canadian breast and breast-ovarian cancer families  Journal Articles
• Linking Intermediate to Final “Real-World” Outcomes: Is Financial Toxicity a Reliable Predictor of Poorer Outcomes in Cancer?  Journal Articles
• Liposomal delivery of gene therapy for ovarian cancer: a systematic review  Journal Articles
• Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes  Conferences
• Malignant Ascites Fluid (MAF), Including Ovarian-Cancer-Associated MAF, Contains Angiostatin and Other Factor(s) Which Inhibit Angiogenesis  Journal Articles
• Malignant Transformation Within Ovarian Dermoid Cysts  Journal Articles
• Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer  Journal Articles
• Mehrfachtumoren beim Korpuskarzinom  Journal Articles
• Metastatic Ovarian Carcinoma of Large Intestinal Origin Simulating Primary Ovarian Carcinoma: A Clinicopathologic Study of 25 Cases  Journal Articles
• Mitochondrial membrane potential regulation is independent of c-<i>fos</i> expression  Journal Articles
• Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers  Journal Articles
• Multicenter, Randomized Phase II Trial of Oral CI-1033 for Previously Treated Advanced Ovarian Cancer  Journal Articles
• Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia  Journal Articles
• Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo  Journal Articles
• Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma  Journal Articles
• Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline  Journal Articles
• Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review  Journal Articles
• Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials  Journal Articles
• Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*)  Journal Articles
• Objective Responses in Patients with Malignant Melanoma or Renal Cell Cancer in Early Clinical Studies Do Not Predict Regulatory Approval  Journal Articles
• Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial  Journal Articles
• Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study  Journal Articles
• Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial  Journal Articles
• Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial  Journal Articles
• Oncologists’ Perceptions of Recurrent Ovarian Cancer Patients’ Preference for Participation in Treatment Decision Making and Strategies for When and How to Involve Patients in This Process  Journal Articles
• Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer  Journal Articles
• Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer  Journal Articles
• Orthotopic, syngeneic mouse model to study the effects of epithelial-stromal interaction  Journal Articles
• Outcomes for systemic therapy in women with ovarian cancer  Journal Articles
• Outcomes in Surgery for Ovarian Cancer  Journal Articles
• Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study  Journal Articles
• Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2  Journal Articles
• Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer  Journal Articles
• Overexpression of miR-200s inhibits proliferation and invasion while increasing apoptosis in murine ovarian cancer cells  Journal Articles
• Patients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument  Journal Articles
• Patterns of care in the initial management of women with ovarian cancer in Ontario.  Journal Articles
• Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer  Journal Articles
• Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer  Journal Articles
• Phase I Clinical Trial of Recombinant Human Interleukin-3 Combined With Carboplatin in the Treatment of Patients With Recurrent Ovarian Carcinoma  Journal Articles
• Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study  Journal Articles
• Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors  Journal Articles
• Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia  Conferences
• Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy  Journal Articles
• Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)☆  Journal Articles
• Phase II study of mitomycin C and 5 fluorouracil in platinum resistant ovarian cancer.  Journal Articles
• Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours  Journal Articles
• Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I  Journal Articles
• Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance  Journal Articles
• Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation  Journal Articles
• Physicians' attitudes, beliefs and knowledge concerning ovarian cancer.  Journal Articles
• Physicochemical Characterization of Ferrocifen Lipid Nanocapsules: Customized Drug Delivery Systems Guided by the Molecular Structure  Journal Articles
• Pleural Effusion Detected at CT prior to Primary Cytoreduction for Stage III or IV Ovarian Carcinoma: Effect on Survival  Journal Articles
• Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab  Journal Articles
• Practice guidelines for BRCA1/2 tumour testing in ovarian cancer  Journal Articles
• Preoperative identification of a suspicious adnexal mass: A systematic review and meta-analysis  Journal Articles
• Pro-apoptotic and anti-angiogenic actions of 2-methoxyestradiol and docosahexaenoic acid, the biologically derived active compounds from flaxseed diet, in preventing ovarian cancer  Journal Articles
• Proceedings of the Second NCI–SNMMI Workshop on Targeted Radionuclide Therapy  Journal Articles
• Prognostic Significance of Supradiaphragmatic Lymphadenopathy Identified on Preoperative Computed Tomography Scan in Patients Undergoing Primary Cytoreduction for Advanced Epithelial Ovarian Cancer  Journal Articles
• Prognostic factors for women with Stage 1 ovarian cancer with or without adhesions.  Journal Articles
• Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer  Journal Articles
• Prophylactic oophorectomy in Ontario.  Journal Articles
• Prostate‐Specific antigen expression by various tumors  Journal Articles
• Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer.  Journal Articles
• Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer  Journal Articles
• Rates of genetic consultation in high-grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population-based study.  Journal Articles
• Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity  Journal Articles
• Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival  Journal Articles
• Reversal of suppression of lymphokine-activated killer cells by transforming growth factor-β in ovarian carcinoma ascitic fluid requires interleukin-2 combined with anti-CD3 antibody  Journal Articles
• Risk factors for ovarian cancer and early-onset breast cancer in Mongolia.  Journal Articles
• Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).  Journal Articles
• Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis  Journal Articles
• Role of the transcription factor Ets-1 in cisplatin resistance  Journal Articles
• Role of trypsin and protease-activated receptor-2 in ovarian cancer.  Journal Articles
• Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial  Journal Articles
• Safety and Efficacy of Patupilone in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer: A Phase I, Open-Label, Dose-Escalation Study  Journal Articles
• Screening Postmenopausal Women for Ovarian Cancer: A Systematic Review  Journal Articles
• Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.  Journal Articles
• Selecting a BRCA risk assessment model for use in a familial cancer clinic  Journal Articles
• Sertoliform Endometrioid Carcinoma of the Ovary: A Potential Diagnostic Pitfall  Journal Articles
• Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.  Journal Articles
• Solitary fibrous tumor (SFT) of the pelvis  Journal Articles
• Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium  Journal Articles
• Squamous Lesions of the Ovary  Journal Articles
• Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial  Journal Articles
• Stop, Think, and Re-evaluate: A Decidualized Endometrioma can Mimic Malignancy in Pregnancy  Journal Articles
• Subacute cor pulmonale due to tumor embolization.  Journal Articles
• Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants  Journal Articles
• Surgical management of a suspicious adnexal mass: A systematic review  Journal Articles
• Surgical outcomes in women with ovarian cancer.  Journal Articles
• Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands  Journal Articles
• Systematic review of adjuvant care for women with Stage I ovarian carcinoma  Journal Articles
• Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer  Journal Articles
• Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition  Journal Articles
• Telomerase activity associated with acquisition of malignancy in human colorectal cancer.  Journal Articles
• Telomerase activity in human ovarian carcinoma.  Journal Articles
• Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992–2005: A population-based study  Journal Articles
• The Cancer-associated K351N Mutation Affects the Ubiquitination and the Translocation to Mitochondria of p53 Protein  Journal Articles
• The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities  Journal Articles
• The Fallopian Tube as the Origin of High Grade Serous Ovarian Cancer: Review of a Paradigm Shift  Journal Articles
• The Meaning‐Making intervention (MMi) appears to increase meaning in life in advanced ovarian cancer: a randomized controlled pilot study  Journal Articles
• The Quality of the Operative Report for Women With Ovarian Cancer in Ontario  Journal Articles
• The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer  Journal Articles
• The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers  Journal Articles
• The chemotherapy of granulosa cell tumors of the ovary: Experience of the wisconsin clinical cancer center  Journal Articles
• The endothelin-1-driven tumor-stroma feed-forward loops in high-grade serous ovarian cancer  Journal Articles
• The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation  Journal Articles
• The impact of prophylactic salpingo‐oophorectomy on quality of life and psychological distress in women with a BRCA mutation  Journal Articles
• The impact of the ovarian microenvironment on the anti-tumor effect of SPARC on ovarian cancer¹This article is part of Special Issue entitled Asilomar Chromatin and has undergone the Journal’s usual peer review process.  Journal Articles
• The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT  Journal Articles
• The risks of cancer in older women with BRCA pathogenic variants: How far have we come?  Journal Articles
• The role of oophoropexy in patients with gynecological cancer who need radiation therapy  Journal Articles
• Timing of Palliative Care, End-of-Life Quality Indicators, and Health Resource Utilization.  Journal Articles
• Transforming Growth Factor α Localization and Role in Surface Epithelium of Normal Human Ovaries and in Ovarian Carcinoma Cells  Journal Articles
• Treatment of clitoromegaly of culturally diverse patients  Journal Articles
• Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol  Conferences
• Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation  Journal Articles
• Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers  Journal Articles
• Two Phase I Studies of Carboplatin Dose Escalation in Chemotherapy-Naive Ovarian Cancer Patients Supported With Patients Supported With Granulocyte-Macrophage Colony-Stimulating Factor  Journal Articles
• UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium  Journal Articles
• Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.  Journal Articles
• Use of systemic therapy in women with recurrent ovarian cancer—Development of a national clinical practice guideline  Journal Articles
• VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents  Journal Articles
• Walking a tightrope: oncologists’ perspective on providing information to women with recurrent ovarian cancer (ROC) during the medical encounter  Journal Articles
• Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers  Conferences
• Women’s perceptions about treatment decision making for ovarian cancer  Journal Articles
• [Risk of ovarian cancer in women treated for infertility].  Journal Articles
• [Risk of ovarian cancer in women treated for infertility].  Journal Articles
• cAMP response element–binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation  Journal Articles
• hMENA is a key regulator in endothelin-1/β-arrestin1–induced invadopodial function and metastatic process  Journal Articles
• miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma  Journal Articles
• β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer  Journal Articles